BACKGROUND: Primary resistance represents a challenge for the control of HIV-1 because it can reduce the efficacy of first line antiretroviral therapy and may impact clinical outcomes. OBJECTIVES: To describe the prevalence of primary HIV-1 drug resistance and subtypes circulating in Central West Brazil. STUDY DESIGN: 103 antiretroviral naïve patients were recruited in Goiânia city, Central West Brazil during 2007-2008. Protease and partial reverse transcriptase regions were retrotranscribed from plasma HIV-1 RNA and 97 were sequenced after direct nested PCR. HIV-1 subtype was assigned by phylogenetic analysis. Primary drug resistance was analyzed by the Calibrated Population Resistance (CPR) tool using Stanford Surveillance Drug Resistance Mutation (SDRM) and International AIDS Society-USA (IAS-USA) major mutation list. RESULTS: Primary drug resistance mutations ranged from 8% (IAS) to 10% (SDRM). High level resistance to at least one antiretroviral drug was observed. T215D/S revertant mutations were identified in 4/97 patients. HIV-1 subtype B represented 82.5%, subtype F1 6.2%, subtype C 3.1%, B/F1 7.2% and one sample was a F1/C/B mosaic. HIV-1 subtype C sequences formed a monophyletic cluster with other Brazilian subtype C sequences. CONCLUSIONS: Our HIV-1 pol sequences from Central West region include the first inland HIV-1 subtype C sequences and help compose the molecular epidemiology map of HIV-1 in Brazil. This data also show that a significant proportion of the naïve patients presented important drug resistance mutations. Therefore naive patients from this setting may benefit from pre-treatment genotypic testing to optimize the choice of antiretroviral drugs and to help control HIV-1 transmission.
BACKGROUND: Primary resistance represents a challenge for the control of HIV-1 because it can reduce the efficacy of first line antiretroviral therapy and may impact clinical outcomes. OBJECTIVES: To describe the prevalence of primary HIV-1 drug resistance and subtypes circulating in Central West Brazil. STUDY DESIGN: 103 antiretroviral naïve patients were recruited in Goiânia city, Central West Brazil during 2007-2008. Protease and partial reverse transcriptase regions were retrotranscribed from plasma HIV-1 RNA and 97 were sequenced after direct nested PCR. HIV-1 subtype was assigned by phylogenetic analysis. Primary drug resistance was analyzed by the Calibrated Population Resistance (CPR) tool using Stanford Surveillance Drug Resistance Mutation (SDRM) and International AIDS Society-USA (IAS-USA) major mutation list. RESULTS: Primary drug resistance mutations ranged from 8% (IAS) to 10% (SDRM). High level resistance to at least one antiretroviral drug was observed. T215D/S revertant mutations were identified in 4/97 patients. HIV-1 subtype B represented 82.5%, subtype F1 6.2%, subtype C 3.1%, B/F1 7.2% and one sample was a F1/C/B mosaic. HIV-1 subtype C sequences formed a monophyletic cluster with other Brazilian subtype C sequences. CONCLUSIONS: Our HIV-1 pol sequences from Central West region include the first inland HIV-1 subtype C sequences and help compose the molecular epidemiology map of HIV-1 in Brazil. This data also show that a significant proportion of the naïve patients presented important drug resistance mutations. Therefore naive patients from this setting may benefit from pre-treatment genotypic testing to optimize the choice of antiretroviral drugs and to help control HIV-1 transmission.
Authors: Zelma Bernades da Costa; Yanna Andressa Ramos de Lima; Celina Maria Turchi Martelli; Mariane Martins de Araújo Stefani Journal: AIDS Patient Care STDS Date: 2013-08 Impact factor: 5.078
Authors: Ludimila Paula Vaz Cardoso; Alexsander Augusto da Silveira; Roberta Barbosa Lopes Francisco; Mônica Nogueira da Guarda Reis; Mariane Martins de Araújo Stefani Journal: AIDS Res Hum Retroviruses Date: 2011-07-06 Impact factor: 2.205
Authors: Alexsander Augusto da Silveira; Ludimila Paula Vaz Cardoso; Roberta Barbosa Lopes Francisco; Mariane Martins de Araújo Stefani Journal: AIDS Res Hum Retroviruses Date: 2011-07-26 Impact factor: 2.205
Authors: Sabrina Em Almeida; Rubia M de Medeiros; Dennis M Junqueira; Tiago Gräf; Caroline P B Passaes; Gonzalo Bello; Mariza G Morgado; Monick L Guimarães Journal: Virol J Date: 2012-12-12 Impact factor: 4.099
Authors: Joel O Wertheim; Andrew J Leigh Brown; N Lance Hepler; Sanjay R Mehta; Douglas D Richman; Davey M Smith; Sergei L Kosakovsky Pond Journal: J Infect Dis Date: 2013-10-22 Impact factor: 5.226
Authors: Edson Delatorre; José C Couto-Fernandez; Monick Lindenmayer Guimarães; Ludimila Paula Vaz Cardoso; Keila Correia de Alcantara; Mariane Martins de Araújo Stefani; Hector Romero; Caio C M Freire; Atila Iamarino; Paolo M de A Zanotto; Mariza G Morgado; Gonzalo Bello Journal: PLoS One Date: 2013-09-12 Impact factor: 3.240
Authors: Celina M P de Moraes Soares; Tania R C Vergara; Carlos Brites; Jose D U Brito; Gorki Grinberg; Marcos M Caseiro; Carlos Correa; Theodoro A Suffert; Flavio R Pereira; Michelle Camargo; Luiz M Janini; Shirley Komninakis; Maria C A Sucupira; Ricardo S Diaz Journal: J Int AIDS Soc Date: 2014-09-22 Impact factor: 5.396